Iguana Healthcare Management’s Alkermes ALKS Stock Holding History

Iguana Healthcare Management’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-30,000	Closed	-$1.3M	–	81
2016 Q2	$1.3M	Buy	+30,000	New	+$1.24M	0.53%	60
2015 Q1	–	Sell	-50,000	Closed	-$2.93M	–	63
2014 Q4	$2.93M	Sell	50,000 -10,000	-17%	-$509K	1.42%	30
2014 Q3	$2.57M	Sell	60,000 -25,000	-29%	-$1.12M	1.37%	29
2014 Q2	$4.28M	Sell	85,000 -15,000	-15%	-$692K	2%	17
2014 Q1	$4.41M	Buy	100,000 +25,000	+33%	+$1.19M	2.04%	14
2013 Q4	$3.05M	Buy	+75,000	New	+$2.77M	1.74%	19

Other funds holding ALKS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Iguana Healthcare Management's ALKS Position: Q3 2016 in Review

Iguana Healthcare Management sold out of Alkermes (ALKS) in Q3 2016, closing a stake of 30,000 shares — an estimated $1.3M sold.

Iguana Healthcare Management first reported a position in ALKS in Q4 2013 and held it in 6 quarters. The position peaked at $4.41M in Q1 2014. 259 funds tracked by Wall St. Rank hold ALKS as of Q3 2016.

Iguana Healthcare Management reported no remaining Alkermes position as of Q3 2016 after selling out during the quarter.
Iguana Healthcare Management sold 30,000 Alkermes shares in Q3 2016, an estimated $1.3M.
Iguana Healthcare Management first reported a position in Alkermes in Q4 2013 and held it in 6 quarters.
Iguana Healthcare Management's Alkermes position peaked at $4.41M in Q1 2014.
259 funds tracked by Wall St. Rank held Alkermes as of Q3 2016.

Based on Iguana Healthcare Management's 13F filing for Q3 2016, filed 14 Nov 2016.